Pfizer Inc. and Allergan PLC are about to reach a $150 billion deal that would create the world’s largest drugmaker by sales.
What the actual scenarios is?
This deal between Pfizer and Botox maker Allergan would be the largest corporate merger so far this year. Pfizer has a market cap of $199 billion; while Allergan has a market cap of $123 billion. The companies’ boards of directors are reportedly expected to approve the deal. This deal would cap a remarkable consolidation wave roiling the U.S. healthcare industry and it would create the world’s biggest drug maker by sales.
This deal is likely to fuel critics who fear that now consumers would pay even more for drugs as competition declines among manufacturers, insurers and retailers.